The Brazilian state will test the Russian vaccine, eyes are buying 50 million doses

Officials say the Brazilian state of Bahia has signed an agreement to conduct Phase III clinical trials of Russia's Sputnik V vaccine against Covid 19, and plans to buy 50 million doses for the market in Brazil.

The Brazilian state will test the Russian vaccine, eyes are buying 50 million doses

The Russian vaccine is being developed’ by the Gamaleya Research Institute in Moscow and is being marketed by the Russian Foreign Investment Fund (RDIF), which last month tested and developed the vaccine with the Brazilian state of Parana. What was the agreement?

Russia will sell 50 million doses of its COVID-19 vaccine to the Brazilian state of Bahia under the name Sputnik-V, the RDIF said in a statement.

Governor Rui Costa said an agreement had been reached’ this week to prosecute and that Bahia would receive an initial 500 doses as soon as Brazilian health regulator Anvisa approved the protocol for testing.

The RDIF added that the first supply would begin "with consideration of the outcome of post-registration cases" after approval by Brazilian regulators in November.

Russia has listed Sputnik as the world's first vaccine against coronavirus, although Phase III trials are still pending.

The Phase III trial is a large-scale one involving thousands of people - in Russia, 40,000 - over a long period of time.

If the trials are expected’ to pass in October, Bahia will market the Russian vaccine in Brazil through its pharmaceutical research center, Bahiafarma, said Navy State Health Secretary Fabio Vilas Bose Pinto.

Brazil is the world's third most difficult country to be infected’ with the corona virus, with more than a million confirmed cases.

The Institute for Technology, set up for the state of Parana, said last week that a separate Phase II trial would also be held’ on 10,000 volunteers in Brazil in 2021.

ParanĂ¡'s Institute of Technology, known as Tecpar, will use imported doses for testing, but will begin developing vaccines for the Brazilian market in the second half of next year.

RDIF has already signed two deals to export the vaccine. Kazakhstan is initially ready to buy more than 2 million doses and could later increase the volume to 5 million doses.

It has also agreed to sell 32 million doses to a Mexican private company, Landsteiner Scientific.

The RDIF said this week that it expects to supply 100 million doses of the vaccine to Latin America, close to one-fifth of what it expects to be able to produce annually through a global manufacturing partnership.

India will produce 300 million doses of the vaccine.


Russia says it has timeline for Navalny movements, wants to send investigators to Germany

Post a Comment